BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8228818)

  • 1. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.
    Graham MB; Dalton DK; Giltinan D; Braciale VL; Stewart TA; Braciale TJ
    J Exp Med; 1993 Nov; 178(5):1725-32. PubMed ID: 8228818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
    Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
    J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung.
    Warren TK; Mitchell KA; Lawrence BP
    Toxicol Sci; 2000 Jul; 56(1):114-23. PubMed ID: 10869459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.
    Pertmer TM; Roberts TR; Haynes JR
    J Virol; 1996 Sep; 70(9):6119-25. PubMed ID: 8709236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of IFN-gamma leads to increased Th2 responses after influenza A virus infection characterized by an increase in CD4+ but not CD8+ T cells producing IL-4 or IL-5 in the lung.
    Wohlleben G; Erb KJ
    Immunol Lett; 2004 Sep; 95(2):161-6. PubMed ID: 15388256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene.
    Liu B; Mori I; Hossain MJ; Dong L; Chen Z; Kimura Y
    Microb Pathog; 2003 Apr; 34(4):161-7. PubMed ID: 12668139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
    Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
    J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner.
    Weiss ID; Wald O; Wald H; Beider K; Abraham M; Galun E; Nagler A; Peled A
    J Interferon Cytokine Res; 2010 Jun; 30(6):439-49. PubMed ID: 20235626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice.
    Jayasekera JP; Vinuesa CG; Karupiah G; King NJC
    J Gen Virol; 2006 Nov; 87(Pt 11):3361-3371. PubMed ID: 17030871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of gamma interferon during the recall response to influenza virus.
    Bot A; Bot S; Bona CA
    J Virol; 1998 Aug; 72(8):6637-45. PubMed ID: 9658110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.
    Price GE; Gaszewska-Mastarlarz A; Moskophidis D
    J Virol; 2000 May; 74(9):3996-4003. PubMed ID: 10756011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue.
    Baumgarth N; Kelso A
    J Virol; 1996 Jul; 70(7):4411-8. PubMed ID: 8676464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.
    Van Der Sluijs KF; Van Elden LJ; Arens R; Nijhuis M; Schuurman R; Florquin S; Kwakkel J; Akira S; Jansen HM; Lutter R; Van Der Polls T
    Immunology; 2005 Jan; 114(1):112-20. PubMed ID: 15606801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to Trichinella spiralis infection in vitamin A-deficient mice.
    Carman JA; Pond L; Nashold F; Wassom DL; Hayes CE
    J Exp Med; 1992 Jan; 175(1):111-20. PubMed ID: 1730911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice.
    Kostense S; Sun WH; Cottey R; Taylor SF; Harmeling S; Zander D; Small PA; Bender BS
    Antiviral Res; 1998 May; 38(2):117-30. PubMed ID: 9707374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA; Esser MT; Fuller CL; Lam Braciale V
    J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.
    Liu Y; Zheng J; Liu Y; Wen L; Huang L; Xiang Z; Lam KT; Lv A; Mao H; Lau YL; Tu W
    Cell Mol Immunol; 2018 Sep; 15(9):827-837. PubMed ID: 28413216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection.
    Graham MB; Braciale VL; Braciale TJ
    J Exp Med; 1994 Oct; 180(4):1273-82. PubMed ID: 7931062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
    Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
    J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.